Evidence map›Paper›PMID 38338439›Full record

ArticleMolecules (Basel, Switzerland)2024

Development of Biological Coating from Novel Halophilic Exopolysaccharide Exerting Shelf-Life-Prolonging and Biocontrol Actions for Post-Harvest Applications.

Chandni Upadhyaya, Hiren Patel, Ishita Patel, Parth Ahir, Trushit Upadhyaya

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
4.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Chandni UpadhyayaSchool of Sciences, P. P. Savani University, Surat 394125, Gujarat, India.ORCID 0000-0001-8601-6203
Hiren PatelSchool of Sciences, P. P. Savani University, Surat 394125, Gujarat, India.ORCID 0000-0003-0085-2695
Ishita PatelShree P. M. Patel Institute of Integrated M. Sc. in Biotechnology, Sardar Patel University, Anand 388001, Gujarat, India.ORCID 0000-0003-2491-351X
Parth AhirShree P. M. Patel Institute of P. G. Studies in Research and Sciences, Sardar Patel University, Anand 388001, Gujarat, India.
Trushit UpadhyayaChandubhai S. Patel Institute of Technology, Charotar University of Science & Technology, Changa, Anand 388421, Gujarat, India.ORCID 0000-0001-8922-8201
Sardar Patel University · INCharotar University of Science and Technology · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The literature presents the preserving effect of biological coatings developed from various microbial sources. However, the presented work exhibits its uniqueness in the utilization of halophilic exopolysaccharides as food coating material. Moreover, such extremophilic exopolysaccharides are more stable and economical production is possible. Consequently, the aim of the presented research was to develop a coating material from marine exopolysaccharide (EPS). The significant EPS producers having antagonistic attributes against selected phytopathogens were screened from different marine water and soil samples. TSIS01 isolate revealed the maximum antagonism well and EPS production was selected further and characterized as

Indexed as

GlucosePolysaccharides, BacterialAntioxidantsHumansRNA, Ribosomal, 16SSpectroscopy, Fourier Transform InfraredSugarsWaterAntioxidantsGlucosePolysaccharides, BacterialRNA, Ribosomal, 16SSugarsWaterantagonistic attributescoating material% disease incidencemarine exopolysaccharide

Identifiers

PMID38338439
PMCPMC10856335
OpenAlexW4391472790

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.